Fundraising Fox
DemeRx
Fort Lauderdale, US · Founded 2010 · Florida corporation
Find your way into DemeRx
15 people in our graph share verified history with the DemeRx team — schools, employers, funds. One of them is your warm intro.
Adam Handfingerunlockedknows Deborah C. Mash · together at Nova Southeastern University (overlapped)
knows the team · via Nova Southeastern University
×10knows the team · via University of Miami Miller School of Medicine
DemeRx develops psychedelic-based medications to treat addiction and mental health conditions. The company advances clinical trials for ibogaine and related compounds targeting alcohol use disorder and opioid addiction.
Founders & leadership
DemeRx was founded in 2010 by Deborah C. Mash.
DC
Deborah C. MashDeborah C. Mash has expertise in small molecule development, pharmacology, addiction neurobiology, and neuroscience, and is founder of DemeRx, which develops psychedelic-based medications for addiction and mental health conditions.
HW
Holger WeisExecutive
JL
Jeffrey L. RaneyExecutive
SG
Steve GorlinNamed on SEC filing
Board
HM
Henry MellonBoard director
CK
Charles KoobBoard director
BH
Bruce HackBoard director
PN
Peter NejesBoard director
SC
Skip ClemmonsBoard director
Reported raises · per SEC filings
Form D private placements$289.6K disclosed across 1 round · 2015
▶$289.6KraisedMay 2015 · 9 investors · PharmaceuticalsRule 506(b)
▶$289.6KraisedMay 2015 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Henry MellonDirector
- Holger WeisExecutive Officer
- Jeffrey L. RaneyExecutive Officer
- Charles KoobDirector
- Bruce HackDirector
- Peter NejesDirector
- Steve GorlinDirector
- Skip ClemmonsDirector
- Offering amount
- $500K
- Amount sold
- $289.6K
- Minimum investment
- $1K
- First sale
- Apr 2015
- Incorporated
- Corporation, Florida, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does DemeRx do?
- DemeRx develops psychedelic-based medications to treat addiction and mental health conditions. The company advances clinical trials for ibogaine and related compounds targeting alcohol use disorder and opioid addiction.
- Who founded DemeRx?
- DemeRx was founded by Deborah C. Mash in 2010.
- How much funding has DemeRx raised?
- DemeRx has disclosed $289.6K raised across 1 round.
- Where is DemeRx headquartered?
- DemeRx is headquartered in Fort Lauderdale, US.